Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Behav Brain Res ; 459: 114793, 2024 02 29.
Article in English | MEDLINE | ID: mdl-38048909

ABSTRACT

This study investigated the antinociceptive potential of cannabidiol (CBD) in male and female Wistar rats. The assessment and analysis included tail withdrawal to thermal stimulation (tail flick test) and mechanical allodynia induced by plantar incision injury (von Frey test). CBD reduced acute thermal sensitivity in uninjured animals and post-operative mechanical allodynia in males and females. In the tail flick test, CBD 30 mg/kg i.p. was required to induce antinociception in males. During the proestrus phase, females did not show a statistically significant antinociceptive response to CBD treatment despite a noticeable trend. In contrast, in a separate group of rats tested during the late diestrus phase, antinociception varied with CBD dosage and time. In the post-operative pain model, CBD at 3 mg/kg decreased mechanical allodynia in males. Similarly, this dose reduced allodynia in females during proestrus. However, in females during late diestrus, the lower dose of CBD (0.3 mg/kg) reduced mechanical allodynia, although the latency to onset of the effect was slower (90 min). The effectiveness of a 10-fold lower dose of CBD during the late diestrus stage in females suggests that ovarian hormones can influence the action of CBD. While CBD has potential for alleviating pain in humans, personalized dosing regimens may need to be developed to treat pain in women.


Subject(s)
Cannabidiol , Rats , Female , Male , Humans , Animals , Cannabidiol/pharmacology , Hyperalgesia/drug therapy , Rats, Wistar , Pain, Postoperative/drug therapy , Analgesics/pharmacology , Analgesics/therapeutic use
2.
J Psychopharmacol ; 36(11): 1257-1272, 2022 11.
Article in English | MEDLINE | ID: mdl-36239034

ABSTRACT

BACKGROUND: Panic-like reactions elicited by electrical stimulation of the dorsal periaqueductal grey matter (ES-dPAG) seem to be regulated by dopamine (DA). We showed that DA applied intranasally (IN) increased escape-behaviour thresholds induced by ES-dPAG of rats, indicating a panicolytic-like effect. AIMS: We investigated whether IN-DA increases escape-response thresholds induced by ES-dPAG by acting on D2-like receptors, and whether IN-DA affects escape responses elicited by the presence of a potential predator and by open space and height of the elevated T-maze (ETM) as well as motor performance in the open field (OF) test. METHODS: Wistar rats exposed to ES-dPAG were treated with Sulpiride (SUL, 40 mg/kg, D2-like receptor antagonist) previously IN-DA (2 mg/kg). Independent groups of rats treated with IN-DA were submitted to prey versus snake paradigm (PSP), ETM and OF. RESULTS: Anti-aversive effects of the IN-DA were reduced by SUL pretreatment in the ES-dPAG test. IN-DA did not affect the escape number in the PSP nor the escape latencies in the ETM as well as motor performance in the OF. CONCLUSIONS/INTERPRETATION: The IN-DA effects in reducing unconditioned fear responses elicited by ES-dPAG seem to be mediated by D2-like receptors. The lack of effects on panic-related responses in the ETM and PSP may be related to the possibility of avoiding the danger inherent to these models, a defence strategy not available during ES-dPAG. These findings cannot be attributed to motor performance. The decision-making responses to avoid dangerous situations can be orchestrated by supra-mesencephalic structures connected by non-dopaminergic inputs.


Subject(s)
Crotalinae , Periaqueductal Gray , Rats , Animals , Dopamine/pharmacology , Rats, Wistar , Fear , Electric Stimulation , Escape Reaction
3.
Behav Brain Res ; 417: 113611, 2022 01 24.
Article in English | MEDLINE | ID: mdl-34592376

ABSTRACT

Fear extinction (FExt) is used to treat patients with posttraumatic stress disorder (PTSD). However, fear related to traumatic events can be persistent and return even after successful extinction. The neurochemical control of extinction seems to be performed by several neurotransmitters, including dopamine (DA), through D1 and D2 receptors. Recently, we showed that intranasally applied DA (IN-DA) facilitated the FExt, but the mechanisms by which it promoted this effect are still unknown. This study focused on investigating whether these effects are mediated by the action of DA on D2-like receptors since these receptors seem to be related to neurochemical and molecular changes underlying extinction. Also, we investigated whether IN-DA treatment would affect conditioned fear-induced antinociception (Fear-IA). Rats treated with IN-DA (1 mg/kg) twenty-five minutes after sulpiride (SUL; 40 mg/kg, i.p., D2-antagonist) were subjected to the extinction of contextual fear. IN-DA applied before the extinction session induced the FExt and prevented Fear-IA. These effects were impaired by pre-treatment with SUL, suggesting that the IN-DA effects are mediated by DA on D2-like receptors. SUL per se also facilitated the FExt but did not affect Fear-IA. These data suggest IN-DA as a promising pharmacological tool to supplement the psychotherapy of patients suffering from PTSD.


Subject(s)
Conditioning, Psychological/physiology , Dopamine D2 Receptor Antagonists/pharmacology , Dopamine/pharmacology , Extinction, Psychological/physiology , Fear/physiology , Receptors, Dopamine D2/physiology , Sulpiride/pharmacology , Administration, Intranasal , Animals , Conditioning, Psychological/drug effects , Dopamine Agents/pharmacology , Extinction, Psychological/drug effects , Male , Rats , Sulpiride/antagonists & inhibitors
4.
Neurobiol Stress ; 12: 100219, 2020 May.
Article in English | MEDLINE | ID: mdl-32435668

ABSTRACT

Avoidance behavior is a hallmark in pathological anxiety disorders and results in impairment of daily activities. Individual differences in avoidance responses are critical in determining vulnerability or resistance to anxiety disorders. Dopaminergic activation is implicated in the processing of avoidance responses; however, the mechanisms underlying these responses are unknown. In this sense, we used a preclinical model of avoidance behavior to investigate the possibility of an intrinsic differential dopaminergic pattern between good and poor performers. The specific goal was to assess the participation of dopamine (DA) through pharmacological manipulation, and we further evaluated the effects of systemic injections of the dopaminergic receptor type 1 (D1 antagonist - SCH23390) and dopaminergic receptor type 2 (D2 antagonist - sulpiride) antagonists in the good performers. Additionally, we evaluated the effects of intra-amygdala microinjection of a D1 antagonist (SCH23390) and a D2 antagonist (sulpiride) in good performers as well as intra-amygdala microinjection of a D1 agonist (SKF38393) and D2 agonist (quinpirole) in poor performers. Furthermore, we quantified the contents of dopamine and metabolites (3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA)) in the amygdala, evaluated the basal levels of tyrosine hydroxylase expression (catecholamine synthesis enzyme) and measured the volume of the substantia nigra, ventral tegmental area and locus coeruleus. Our results showed that it could be possible to convert animals from good to poor performers, and vice versa, by intra-amygdala (basolateral and central nucleus) injections of D1 receptor antagonists in good performers or D2 receptor agonists in poor performers. Additionally, the good performers had lower levels of DOPAC and HVA in the amygdala, an increase in the total volume of the amygdala (AMG), substantia nigra (SN), ventral tegmental area (VTA) and locus coeruleus (LC), and an increase in the number of tyrosine hydroxylase-positive cells in SN, VTA and LC, which positively correlates with the avoidance behavior. Taken together, our data show evidence for a dopaminergic signature of avoidance performers, emphasizing the role of distinct dopaminergic receptors in individual differences in avoidance behavior based on pharmacological, immunohistochemical, neurochemical and volumetric analyses. Our findings provide a better understanding of the role of the dopaminergic system in the execution of avoidance behavior.

5.
J Psychopharmacol ; 33(12): 1524-1532, 2019 12.
Article in English | MEDLINE | ID: mdl-31328620

ABSTRACT

PURPOSE: Intranasally applied dopamine (IN-DA), which likely reaches the brain via nasal-brain pathways and bypasses the blood-brain barrier, has been found to increase extracellular DA and bind to the DA2 transporter in the striatum. Recent studies suggest that DA plays a significant role in the processing of signaled and unconditioned aversive stimulation, including evidence that may attenuate responses to painful input. The purpose of this study was to examine the effects of IN-DA on fear-related behaviors induced by electric shock to the foot or by electrical stimulation of the dorsal periaqueductal gray matter (dPAG). METHODS: DA hydrochloride suspended in a viscous castor oil gel (1 or 2 mg/kg) was applied (IN-DA) in a volume of 5 µL into the nostrils of adult Wistar male rats in order to evaluate its effects on (a) freezing induced by electric shock to the foot and (b) thresholds of freezing and escape and duration of post-stimulation freezing induced by electrical stimulation of the dPAG. RESULTS: IN-DA attenuated freezing induced by electric shock to the foot in the three test trials, indicating that it reduced long-term fear responses. IN-DA also increased the threshold of dPAG stimulation-induced escape responses and reduced post-stimulation freezing. CONCLUSIONS: IN-DA, which has previously been shown to facilitate learning and to have antidepressive-like effects, attenuated unconditioned fear responses elicited by peripheral and intramesencephalic (dPAG) stimulation and reduced long-term conditioned fear responses.


Subject(s)
Dopamine/pharmacology , Electric Stimulation , Fear/drug effects , Periaqueductal Gray/metabolism , Administration, Intranasal , Animals , Behavior, Animal/drug effects , Dopamine/administration & dosage , Electroshock , Escape Reaction/drug effects , Male , Rats , Rats, Wistar , Time Factors
6.
J Psychopharmacol ; 33(5): 548-557, 2019 05.
Article in English | MEDLINE | ID: mdl-31012390

ABSTRACT

BACKGROUND AND AIMS: We sought a robust behavioural test that evoked increased anxiety-like behaviour during the late dioestrus phase of the oestrous cycle (similar to the premenstrual period in women) and tested whether this could be prevented by acute low-dose fluoxetine (FLX). METHODS: Female Wistar rats in different stages of their cycle were exposed to four different tests of anxiety-like behaviour. RESULTS: No oestrous cycle differences were detected in fear potentiated startle or conditioned freezing to an aversive context. In a light switch-off test where rats move from one compartment of a shuttle-box to the other to turn off an aversive light, females displayed enhanced responding in late dioestrus. During isolation restraint stress females in late dioestrus emitted three times more 22 kHz ultrasound vocalisations (USV) than at other cycle stages. Using the USV test, short-term administration of low-dose FLX (1.75 mg kg-1, i.p.) designed to blunt the sharp fall in brain allopregnanolone concentration during late dioestrus but without affecting 5-HT systems, prevented the increase in isolation stress-evoked USVs. CONCLUSIONS: The light switch-off and isolation restraint-induced USV tests evoke unconditioned adverse emotional responses that are ethologically relevant and sensitive to oestrous cycle stage. The USV test fulfils many criteria required of a model for premenstrual syndrome in women. Using the USV test, short-term administration of FLX to increase brain allopregnanolone concentration without affecting 5-HT systems prevented the increased USV responding in late dioestrus. Short-term low-dose FLX treatment may have potential to alleviate development of adverse premenstrual symptoms in women.


Subject(s)
Anxiety/metabolism , Anxiety/prevention & control , Behavior, Animal/drug effects , Estrous Cycle/metabolism , Fluoxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Animals , Disease Models, Animal , Fear/drug effects , Female , Fluoxetine/administration & dosage , Rats , Rats, Wistar , Reflex, Startle/drug effects , Selective Serotonin Reuptake Inhibitors/administration & dosage , Vocalization, Animal/drug effects
7.
Brain Res ; 1715: 156-164, 2019 07 15.
Article in English | MEDLINE | ID: mdl-30898678

ABSTRACT

Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results in painful conditions. Then, we aimed to investigate the potential antinociceptive effect of CBD over the mechanical allodynia in streptozotocin-induced diabetic (DBT) rats, as well as its involved mechanisms. Wistar adult male diabetic rats were treated acutely or sub-chronically (for 14 days) with CBD (0.1, 0.3 or 3 mg/kg, intraperitoneal; i.p.) and had their mechanical threshold assessed using the electronic Von Frey. Acute treatment with CBD (at doses of 0.3 and 3 mg/kg) exerted a significant anti-allodynic effect, which is not associated with locomotor impairment. The antinociceptive effect of CBD (3 mg/kg) was not altered by the pre-treatment with CB1 or CB2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) nor by glycine receptor antagonist (strychnine hydrochloride, 10 µg/rat, intrathecal, i.t.). However, this effect was completely prevented by the pre-treatment with the selective 5-HT1A receptor antagonist WAY 100135 (3 µg/rat, i.t.). Sub-chronic treatment with CBD (0.3 or 3 mg/kg) induced a sustained attenuation of the mechanical allodynia in DBT rats. DBT rats presented significantly lower spinal cord levels of serotonin, which was prevented by the daily treatment with CBD (0.3 mg/kg). Taken together, our data suggest that CBD may be effective in the treatment of painful diabetic neuropathy and this effect seems to be potentially mediated by the serotonergic system activation through 5-HT1A receptors.


Subject(s)
Cannabidiol/pharmacology , Hyperalgesia/drug therapy , Receptor, Serotonin, 5-HT1A/drug effects , Animals , Cannabidiol/metabolism , Diabetes Mellitus, Experimental/drug therapy , Disease Models, Animal , Hyperalgesia/metabolism , Male , Neuralgia/drug therapy , Piperazines/pharmacology , Piperidines/pharmacology , Pyrazoles/pharmacology , Pyridines/pharmacology , Rats , Rats, Wistar , Receptor, Serotonin, 5-HT1A/metabolism , Streptozocin/pharmacology
8.
Mol Neurobiol ; 53(10): 6997-7009, 2016 12.
Article in English | MEDLINE | ID: mdl-26671617

ABSTRACT

Diabetes is a chronic disease associated with depression whose pathophysiological mechanisms that associate these conditions are not fully elucidated. However, the activation of the indoleamine-2,3-dioxygenase (IDO), an enzyme that participate of the tryptophan metabolism leading to a decrease of serotonin (5-HT) levels and whose expression is associated with an immune system activation, has been proposed as a common mechanism that links depression and diabetes. To test this hypothesis, diabetic (DBT) and normoglycemic (NGL) groups had the cytokines (TNFα, IL-1ß, and IL-6) and 5-HT and norepinephrine (NE) levels in the hippocampus (HIP) evaluated. Moreover, the effect of the selective serotonin reuptake inhibitor fluoxetine (FLX), IDO direct inhibitor 1-methyl-tryptophan (1-MT), anti-inflammatory and IDO indirect inhibitor minocycline (MINO), or non-selective cyclooxygenase inhibitor ibuprofen (IBU) was evaluated in DBT rats submitted to the modified forced swimming test (MFST). After the behavioral test, the HIP was obtained for IDO expression by Western blotting analysis. DBT rats exhibited a significant increase in HIP levels of TNFα, IL-1ß, and IL-6 and a decrease in HIP 5-HT and NA levels. They also presented a depressive-like behavior which was reverted by all employed treatments. Interestingly, treatment with MINO, IBU, or FLX but not with 1-MT reduced the increased IDO expression in the HIP from DBT animals. Taken together, our data support our hypothesis that neuroinflammation in the HIP followed by IDO activation with a consequent decrease in the 5-HT levels can be a possible pathophysiological mechanism that links depression to diabetes.


Subject(s)
Depression/drug therapy , Diabetes Mellitus, Experimental/psychology , Indoleamine-Pyrrole 2,3,-Dioxygenase/antagonists & inhibitors , Kynurenine/metabolism , Molecular Targeted Therapy , Animals , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Behavior, Animal , Blood Glucose/metabolism , Cytokines/metabolism , Depression/blood , Depression/pathology , Depression/physiopathology , Diabetes Mellitus, Experimental/blood , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Fluoxetine/pharmacology , Fluoxetine/therapeutic use , Hippocampus/metabolism , Hippocampus/pathology , Ibuprofen/pharmacology , Ibuprofen/therapeutic use , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Inflammation Mediators/metabolism , Male , Minocycline/pharmacology , Minocycline/therapeutic use , Motor Activity/drug effects , Norepinephrine/metabolism , Rats, Wistar , Serotonin/metabolism , Swimming , Tryptophan/analogs & derivatives , Tryptophan/pharmacology , Tryptophan/therapeutic use , Weight Gain/drug effects
9.
Neurosci Lett ; 569: 121-5, 2014 May 21.
Article in English | MEDLINE | ID: mdl-24708929

ABSTRACT

The amygdala, together with the dorsal periaqueductal gray (dPAG), medial hypothalamus, and deep layers of the superior and inferior colliculi, constitutes the encephalic aversion system, which has been considered the main neural substrate for the organization of fear and anxiety. The basolateral nucleus of the amygdala (BLA) acts as a filter for aversive stimuli to higher structures while the central (CeA) and the medial (MeA) nuclei constitute the output for the autonomic and somatic components of the emotional reaction through major projections to the limbic and brainstem regions. Although some findings point to the distinct participation of the substance P (SP) and the NK1 receptors system in the different nuclei of the amygdala on the expression of emotional behaviors, it is not clear if this system modulates anxiety-like responses in the distinct nuclei of the amygdala as well as the dPAG. Thus, it was investigated if the injection of SP into the BLA, CeA, or MeA affects the expression of anxiety-like responses of rats submitted to the elevated plus-maze (EPM) test and, if the effects are mediated by NK1 receptors. The results showed that SP and Sar-Met-SP (NK1 receptor selective agonist) injected into the CeA and MeA, but not into the BLA, caused anxiogenic-like effects in the EPM. Altogether, the data indicates that the SP may mimic the effects of anxiogenic stimuli via NK1 receptor activation only in the CeA and MeA (amygdala's nuclei output) and may activate the neural mechanisms involved in the defensive reaction genesis. The SP/NK1 receptors system activation may be phasically involved in very specific aspects of anxiety behaviors.


Subject(s)
Anxiety/psychology , Central Amygdaloid Nucleus/drug effects , Corticomedial Nuclear Complex/drug effects , Receptors, Neurokinin-1/agonists , Substance P/analogs & derivatives , Substance P/pharmacology , Animals , Male , Maze Learning/drug effects , Microinjections , Rats, Wistar
10.
Mov Disord ; 28(14): 2027-32, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24150979

ABSTRACT

BACKGROUND: It is still unclear whether dopamine (DA) levels correlate with Parkinson's disease (PD) severity or play a role in the mechanisms of high-frequency stimulation (HFS). METHODS: We have used microdialysis to record pallidal DA in 5 patients with PD undergoing microelectrode-guided pallidotomy. RESULTS: We found that patients with more severe disease and, consequently, lower pallidal DA did poorly after pallidal lesions. In the operating room, 4 of 5 patients had a significant increase in DA levels during HFS (600%, on average). To test the hypothesis that DA was important for the effects of stimulation, we correlated the amelioration in rigidity observed in the operating room with pallidal DA release. Though rigidity was 56% better during stimulation, no correlation was found between such an improvement and DA release. CONCLUSIONS: These findings suggest that additional mechanisms not directly dependent on pallidal DA release may be involved in the clinical effects of HFS of the globus pallidus internus.


Subject(s)
Deep Brain Stimulation/methods , Dopamine/metabolism , Globus Pallidus/physiology , Parkinson Disease/therapy , Aged , Biophysics , Chromatography, Liquid , Female , Humans , Intraoperative Period , Male , Microdialysis , Middle Aged , Parkinson Disease/metabolism , Severity of Illness Index , Statistics as Topic , Time Factors
11.
Int J Neuropsychopharmacol ; 16(5): 1045-57, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22964037

ABSTRACT

Although dopamine-related circuits are best known for their roles in appetitive motivation, consistent data have implicated this catecholamine in some forms of response to stressful situations. In fact, projection areas of the ventral tegmental area, such as the amygdala and hippocampus, are well established to be involved in the acquisition and expression of fear conditioning, while less is known about the role of the medial prefrontal cortex (mPFC) and nucleus accumbens (NAc) in these processes. In the present study, we initially investigated the involvement of the mPFC and NAc in the expression of conditioned fear, assessing freezing behaviour and Fos protein expression in the brains of rats exposed to a context, light or tone previously paired with footshocks. Contextual and cued stimuli were able to increase the time of the freezing response while only the contextual fear promoted a significant increase in Fos protein expression in the mPFC and caudal NAc. We then examined the effects of specific dopaminergic agonists and antagonists injected bilaterally into the posterior medioventral shell subregion of the NAc (NAcSh) on the expression of contextual fear. SKF38393, quinpirole and sulpiride induced no behavioural changes, but the D1-like receptor antagonist SCH23390 increased the freezing response of the rats and selectively reduced Fos protein expression in the anterior cingulate cortex and rostral NAcSh. These findings confirm the involvement of the NAcSh in the expression of contextual fear memories and indicate the selective role of NAcSh D1-like receptors and anterior cingulate cortex in this process.


Subject(s)
Conditioning, Psychological/physiology , Fear , Gyrus Cinguli/physiology , Nucleus Accumbens/metabolism , Receptors, Dopamine D1/metabolism , Acoustic Stimulation , Analysis of Variance , Animals , Dopamine Agents/pharmacology , Electroshock/adverse effects , Freezing Reaction, Cataleptic/drug effects , Light , Male , Motor Activity/drug effects , Neural Pathways/drug effects , Neural Pathways/physiology , Neural Pathways/physiopathology , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Wistar
12.
Neurobiol Learn Mem ; 95(1): 37-45, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20955808

ABSTRACT

Excitation of the mesocorticolimbic pathway, originating from dopaminergic neurons in the ventral tegmental area (VTA), may be important for the development of exaggerated fear responding. Among the forebrain regions innervated by this pathway, the amygdala is an essential component of the neural circuitry of conditioned fear. The functional role of the dopaminergic pathway connecting the VTA to the basolateral amygdala (BLA) in fear and anxiety has received little attention. In vivo microdialysis was performed to measure dopamine levels in the BLA of Wistar rats that received the dopamine D(2) agonist quinpirole (1 µg/0.2 µl) into the VTA and were subjected to a fear conditioning test using a light as the conditioned stimulus (CS). The effects of intra-BLA injections of the D(1) antagonist SCH 23390 (1 and 2 µg/0.2 µl) and D(2) antagonist sulpiride (1 and 2 µg/0.2 µl) on fear-potentiated startle (FPS) to a light-CS were also assessed. Locomotor performance was evaluated by use of open-field and rotarod tests. Freezing and increased dopamine levels in the BLA in response to the CS were both inhibited by intra-VTA quinpirole. Whereas intra-BLA SCH 23390 did not affect FPS, intra-BLA sulpiride (2 µg) inhibited FPS. Sulpiride's ability to decrease FPS cannot be attributed to nonspecific effects because this drug did not affect motor performance. These findings indicate that the dopamine D(2) receptor pathway connecting the ventral tegmental area and the basolateral amygdala modulates fear and anxiety and may be a novel pharmacological target for the treatment of anxiety.


Subject(s)
Amygdala/physiology , Conditioning, Psychological/physiology , Dopamine/physiology , Fear/physiology , Receptors, Dopamine D2/physiology , Ventral Tegmental Area/physiology , Amygdala/drug effects , Analysis of Variance , Animals , Benzazepines/pharmacology , Chromatography, High Pressure Liquid , Conditioning, Psychological/drug effects , Dopamine Antagonists/pharmacology , Fear/drug effects , Freezing Reaction, Cataleptic/physiology , Male , Microdialysis , Microinjections , Motor Activity/drug effects , Motor Activity/physiology , Rats , Rats, Wistar , Reflex, Startle/drug effects , Reflex, Startle/physiology , Rotarod Performance Test , Sulpiride/pharmacology , Ventral Tegmental Area/drug effects
13.
Behav Brain Res ; 215(1): 63-70, 2010 Dec 20.
Article in English | MEDLINE | ID: mdl-20600337

ABSTRACT

Motor impairments of Parkinson's disease (PD) appear only after the loss of more than 70% of the DAergic neurons of the substantia nigra pars compacta (SNc). An earlier phase of this disease can be modeled in rats that received a unilateral infusion of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) into the SNc. Though these animals do not present gross motor impairments, they rotate towards the lesioned side when challenged with DAergic drugs, like amphetamine and apomorphine. The present study aimed to test whether these effects occur because the drugs disrupt compensatory mechanisms that keep extracellular levels of dopamine in the striatum (DA(E)) unchanged. This hypothesis was tested by an in vivo microdialysis study in awake rats with two probes implanted in the right and left striatum. Undrugged rats did not present turning behaviour and their basal DA(E) did not differ between the lesioned and sham-lesioned sides. However, after apomorphine treatment, DA(E) decreased in both sides, but to a larger extent in the lesioned side at the time the animals started ipsiversive turning behaviour. After amphetamine challenge, DA(E) increased in both sides, becoming significantly higher in the non-lesioned side at the time the animals started ipsiversive turning behaviour. These results are in agreement with the hypothesis that absence of gross motor impairments in this rat model of early phase PD depends on maintenance of extracellular DA by mechanisms that may be disrupted by events demanding its alteration to higher or lower levels.


Subject(s)
Amphetamine/pharmacology , Apomorphine/pharmacology , Corpus Striatum/chemistry , Dopamine/analysis , Stereotyped Behavior/drug effects , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Analysis of Variance , Animals , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid , Corpus Striatum/drug effects , Dopamine Agents/pharmacology , Male , Microdialysis , Rats , Rats, Wistar , Video Recording
14.
Ribeirão Preto; s.n; maio 2009. 85 p. ilus, tab.
Thesis in Portuguese | Index Psychology - journals | ID: psi-42977

ABSTRACT

A substância P (SP) é um neuropeptídeo envolvido em processos relacionados à aprendizagem, memória, medo e ansiedade. O hipocampo, uma das estruturas límbicas envolvidas nesses processos, possui grande quantidade de neurônios que contêm SP e receptores neurocininérgicos. Visto que o hipocampo apresenta alterações neuroquímicas ao longo do seu eixo dorso-ventral, muitos estudos têm mostrado diferenças na expressão de respostas comportamentais associadas a essas alterações. Diante disso, o objetivo deste estudo foi avaliar os efeitos da injeção de SP no hipocampo dorsal (HD) e ventral (HV) de ratos submetidos ao labirinto em cruz elevado (LCE), campo aberto e condicionamento contextual aversivo. Os resultados mostraram que a microinjeção de SP no HD, mas não no HV, aumentou a exploração dos braços abertos do LCE e da área central do campo aberto. Além disso, a SP intra-HD promoveu uma redução do tempo de congelamento de animais expostos ao contexto aversivo onde, previamente, receberam choques nas patas. Esses resultados indicam um efeito anti-aversivo da SP no HD. Com o intuito de investigar se os efeitos promovidos pela SP no HD apresentam uma interação com os mecanismos serotoninérgicos, foram realizados estudos adicionais utilizando a técnica de microdiálise in vivo. A microinjeção de SP no HD em condições basais (não-aversivas) não influenciou a concentração extracelular de serotonina. Os resultados indicam a participação da SP hipocampal na expressão de respostas defensivas e, em condições basais, a independência de seus efeitos de mecanismos serotoninérgicos.(AU)


Substance P (SP) is known to be involved in processes related to learning and memory, tear, anxiety and stress. SP and NK1 receptors are localized in the hippocampus, a brain structure involved in learning and memory as well as emotional processes. As there is evidence for differential functions of the ventral (VH) and dorsal (DH) hippocampus in a variety of behaviors, we here evaluated the effects of injections of SP into the VH and DH in rats submitted to the elevated plus-maze (EPM), open field and contextual tear conditioning. The results showed that infusions of SP into the DH, but not VH, increased open arm exploration in the EPM and in the central zone of the open field. Furthermore, the injection of SP intra- DH promoted a reduction of freezing response in rats submitted to an aversive context previously paired with footshocks. These results indicate an anxiolytic-like effect of SP in the DH. Additional experiment was conducted to examine whether these effects of SP have an interaction with serotoninergic mechanisms. To this end, extracellular concentrations of this monoamine were measured by means of the in vivo microdialysis technique. Infusions of SP into the DH did not change the serotonin extracellular concentrations in basal condition. These data indicate the participation of SP-DH in the expression of defensive responses and, that its effects are dissociated of serotoninergic mechanisms at basal conditions. (AU)


Subject(s)
Animals , Adult , Rats , Hippocampus , Anxiety , Fear , Serotonin
15.
Behav Brain Res ; 182(2): 301-7, 2007 Sep 04.
Article in English | MEDLINE | ID: mdl-17208313

ABSTRACT

Housing conditions change the emotional state of the animals. Ultrasound vocalizations (USVs) termed as 22 kHz are the usual components of the defensive responses of rats exposed to threatening conditions such as isolation. The amount of emission of 22 kHz USVs depends on the intensity of the aversive stimuli. While short periods of isolation caused an anxiolytic-sensitive enhancement of the defensive responses, long-term isolation tended to reduce the defensive performance of the animals to aversive stimuli. The dorsal periaqueductal gray (dPAG) is an important vocal center and a crucial structure for the expression of defensive response. While it has been shown that Substance P (SP) at this midbrain level is involved in the modulation of the defensive response, its role in the emission of ultrasound vocalizations has not been evaluated. In this study we examined whether the resocialization and local injections of SP into the dPAG have an influence on the isolation-induced 22 kHz USVs recorded within the frequency range of 18-26 kHz. Rats isolated for 1 day showed a significant increase in the number and duration of USVs, which were reversed by resocialization. On the other hand, 2-week isolation reduced the number and duration of 22 kHz USVs, which could not be reversed by resocialization. SP injections into the dPAG (35 pmol/0.2 microL) caused a reduction in the 22 kHz USVs. Pretreatment with the NK-1 receptor antagonist spantide (100 pmol/0.2 microL) blocked these effects but exhibited no effect when given alone. These findings suggest that 1-day and 2-week isolation recruit distinct brain defensive systems. Also, in agreement with the notion that intense fear is associated with the neural substrates of fear of the dPAG, activation of NK-1 receptors of this midbrain structure reduces the 22 kHz USVs.


Subject(s)
Periaqueductal Gray/drug effects , Social Isolation , Substance P/pharmacology , Ultrasonics , Vocalization, Animal/drug effects , Analgesics/pharmacology , Analysis of Variance , Animals , Behavior, Animal/drug effects , Drug Interactions , Male , Microinjections/methods , Rats , Rats, Wistar , Substance P/analogs & derivatives , Time Factors , Ultrasonics/classification , Vocalization, Animal/classification , Vocalization, Animal/physiology
16.
Ribeirão Preto; s.n; 2005. 87 p. tab, graf.
Thesis in Portuguese | Index Psychology - Theses | ID: pte-27635

ABSTRACT

O efeito ansiolítico dos benzodiazepínicos (BZDs) é reduzido depois da primeira exposição ao labirinto em cruz elevado (LCE). Várias hipóteses tem sido formuladas para explicar este fenômeno chamado one-trial tolerance (OTT), entretanto, nenhuma delas é conclusiva. No presente estudo, examinamos este fenômeno através da análise etofarmacológica de ratos submetidos ao LCE em duas sessões (T1 e T2), e do conteúdo de monoaminas presentes no córtex pré-frontal, amígdala, hipocampo e núcleo accumbens através da técnica de Cromatografia Líquida de Alta Pressão. Ratos machos Wístar foram tratados com salina ou midazolam (0,5 mg/Kg, i.p.) antes de T1 e T2 e imediatamente depois, seus encéfalos foram dissecados e as estruturas analisadas. Como controle à análise neuroquímica foram incluídos animais tratados com salina e não expostos ao LCE. A administração de midazolam antes de T1 promoveu efeito ansiolítico, aumentando a exploração dos braços abertos, porcentagem de entradas e tempo de permanência nos mesmos. Em T2 foi observado redução da exploração dos braços abertos em relação a T1. Esses resultados sugerem que há uma mudança no estado emocional do animal em T2, que é resistente a ação ansiolítica dos BZDs. Com relação aos resultados dos estudos neuroquímicos, foi observado redução dos conteúdos de serotonina (5-HT) e noradrenalina (NA) no córtex pré-frontal, na amígdala, no hipocampo e no núcleo accumbens depois de T1 e T2. Houve também, redução do conteúdo de dopamina (DA) na amígdala depois de ambas sessões. Não ocorreram mudanças nas taxas de renovação dessas monoaminas em nenhuma das estruturas analisadas. Através desses resultados, pode-se inferir que a estimulação aversiva do LCE causa alterações na neurotransmissão monoaminérgica da amígdala, como também das outras estruturas límbicas estudadas neste trabalho. Essas alterações neuroquímicas depois da primeira exposição ao LCE, devem representar alterações adaptativas na neurotransmissão do sistema límbico que podem estar associadas ao fenômeno da OTT (AU)

SELECTION OF CITATIONS
SEARCH DETAIL
...